The Asian Scientist 100
Yu Min
Academician
Institution
Chinese Academy of Sciences
Country
China
Field
Physics
Yu was given the 2014 National Highest Science and Technology Award, China’s top science award, for his research into hydrogen bombs.
(Photo: Peking University)
Related articles
Magic Glasses Cartoon Halved Worm Infections In Chinese Schoolchildren
Researchers in China and Australia have reported huge success with a cartoon DVD promoting hygiene across rural China.
NTU Confers Honorary Doctorate To Indonesian President
NTU has conferred an honorary doctorate of letters on His Excellency President Susilo Bambang Yudhoyono of the Republic of Indonesia.
Malaysia To Embark On Five-Year RazakSAT-2 Satellite Development Program
The Malaysian government will expand the country’s satellite development program with a RM200 million (US$66 million) boost from the Ministry of Science, Technology and Innovation.
WWF Freshwater Director, Dr. Li Lifeng, Talks To Asian Scientist Magazine
Asian Scientist Magazine chats with Dr. Li Lifeng, Director of the WWF International Freshwater Program, who tells us that solving the water, energy, and food equation for the world has to be a global priority.
In Search Of A Good Dam On The Mekong
Plans to harness hydropower potential in the Lower Mekong Basin for the first time has led to a search for a good dam.
Nuclear Power Plant In Indonesia: To Build Or Not To Build
Plans to build a nuclear power plant in Central Java gained traction after a new survey revealed that the majority of Indonesians support its construction.
Chinese Architect, Wang Shu, Wins 2012 Pritzker Architecture Prize
Wang Shu, a 48-year-old Chinese architect, has been awarded the 2012 Pritzker Architecture Prize, known throughout the world as architecture’s highest honor.
Taiwanese Doctors Show Gene Screening Prevents Drug Reactions
Taiwanese researchers have used genetic screening to prevent two potentially fatal drug-induced syndromes.
D-Pharm Gets South Korean Approval For Phase III Study Of Neuro Drug
D-Pharm Ltd. announced this week that the KFDA has approved the IND application for the Phase III MACSI study of DP-b99 in Korea.









